A Study to Evaluate the Safety and Effectiveness of JIN-A02 in Combination with Amivantamab in Patients with Non-Small Cell Lung Cancer That Has Progressed After Prior EGFR-Targeted Therapy

Authors
Category Primary study
Registry of TrialsKorean Clinical Trials Database
Year 2026
This article has no abstract
Epistemonikos ID: 6be05263bd688fc6e62e65c6b7d08a204a07fac8
First added on: Oct 10, 2026